SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 144 - Report of proposed sale of securities:
SEC Accession No. 0001395064-24-000140
Filing Date
2024-07-10
Accepted
2024-07-10 07:13:59
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 144  
1 primary_doc.xml 144 2890
  Complete submission text file 0001395064-24-000140.txt   4278
Mailing Address 1-1, NIHONBASHI-HONCHO 2-CHOME, CHUO-KU TOKYO M0 103-8668
Business Address 1-1, NIHONBASHI-HONCHO 2-CHOME, CHUO-KU TOKYO M0 103-8668 81332782111
TAKEDA PHARMACEUTICAL CO LTD (Subject) CIK: 0001395064 (see all company filings)

IRS No.: 000000000
Type: 144 | Act: 33 | File No.: 001-38757 | Film No.: 241108677
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 2-1-1 NIHONBASHI-HONCHO TOKYO, CHUO-KU, TOKYO M0 103-8668
Business Address
Weber Christophe Pierre (Reporting) CIK: 0002011270 (see all company filings)

Type: 144